Literature DB >> 30269293

Diffusion-weighted MR in chronic periaortitis, a new technique has entered the clinical arena.

Kevin Kalisz1, Sasan Partovi2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30269293     DOI： 10.1007/s10554-018-1458-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  14 in total

1.  Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.

Authors:  Frederik F Strobl; Axel Rominger; Sarah Wolpers; Carsten Rist; Fabian Bamberg; Kolja M Thierfelder; Konstantin Nikolaou; Christopher Uebleis; Marcus Hacker; Maximilian F Reiser; Tobias Saam
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-24       Impact factor: 2.357

2.  Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up.

Authors:  Rafael Oliveira Caiafa; Ana Sierra Vinuesa; Rafael Salvador Izquierdo; Blanca Paño Brufau; Juan Ramón Ayuso Colella; Carlos Nicolau Molina
Journal:  Radiographics       Date:  2013 Mar-Apr       Impact factor: 5.333

3.  The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.

Authors:  Gabriella Moroni; Massimo Castellani; Aurora Balzani; Roberto Dore; Nicola Bonelli; Selena Longhi; Isabella Martinelli; Piergiorgio Messa; Paolo Gerundini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

4.  Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.

Authors:  Holger Hetterich; Axel Rominger; Lisa Walter; Maximilian Habs; Sarah Volpers; Marcus Hacker; Maximilian F Reiser; Peter Bartenstein; Tobias Saam
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-22       Impact factor: 2.357

Review 5.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

6.  Diffusion-weighted MRI in the follow-up of chronic periaortitis.

Authors:  L Kamper; P Haage; A S Brandt; W Piroth; N Abanador-Kamper; S Roth; H Ekamp
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

7.  (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

Authors:  I Jansen; T R Hendriksz; S H Han; A W L C Huiskes; E F H van Bommel
Journal:  Eur J Intern Med       Date:  2010-03-28       Impact factor: 4.487

8.  Role of gadolinium-enhanced magnetic resonance imaging in retroperitoneal fibrosis.

Authors:  Paul R Burn; Sadmeet Singh; Syed Barbar; Gregory Boustead; Chris M King
Journal:  Can Assoc Radiol J       Date:  2002-06       Impact factor: 2.248

9.  Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation.

Authors:  Riccardo Gorla; Raimund Erbel; Hilmar Kuehl; Philipp Kahlert; Konstantinos Tsagakis; Heinz Jakob; Amir-Abbas Mahabadi; Thomas Schlosser; Andreas Bockisch; Holger Eggebrecht; Eduardo Bossone; Rolf Alexander Jánosi
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-29       Impact factor: 2.357

10.  Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?

Authors:  Marina N Magrey; M Elaine Husni; Irving Kushner; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.